Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News GeneTether Therapeutics Inc C.GTTX

Alternate Symbol(s):  GNTTF

Healthcare
GeneTether Therapeutics Inc. is a Canada-based genetic medicines company focused on creating gene editing therapies based on its proprietary GeneTether platform. The Company's platform technology uses a proprietary method to tether donor deoxyribonucleic acid (DNA) templates to the genome editing complex, making the template readily available for use during the genome editing repair stage. By... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:GTTX)

GeneTether Therapeutics Inc. Announces Fiscal Year 2023 Financial Results and Reports on Corporate Highlights

TheNewsWire March 28, 2024

GeneTether Therapeutics Inc. Announces Third Quarter 2023 Financial Results

TheNewsWire November 28, 2023

GeneTether Therapeutics Board Provides Shareholder Update

TheNewsWire October 20, 2023

GeneTether Therapeutics Inc. Announces Second Quarter 2023 Financial Results

TheNewsWire August 25, 2023

GeneTether Therapeutics Inc. Announces First Quarter 2023 Financial Results and Provides Corporate Update

TheNewsWire May 25, 2023

GeneTether Therapeutics Engages Gad Berdugo, Managing Partner of Explorium Capital LLC, as Advisor to Explore Strategic Alternatives for GeneTether Technology Platform

TheNewsWire May 1, 2023

GeneTether Therapeutics Inc. Announces Fiscal Year 2022 Financial Results and Reports on Corporate Highlights

TheNewsWire April 27, 2023

GeneTether Therapeutics Inc. Update - From the Desk of the CEO

TheNewsWire March 30, 2023

GeneTether Therapeutics Inc. Announces Commencement of Strategic Review Process

TheNewsWire February 8, 2023
View More News ››

Opinion & Analysis (CSE:GTTX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:GTTX)

Yeap ... people are buying at 0.05

This might pop positive soon... just speculating here (but I do see valuations in the 0.05 range).
CashFlowReality - March 12, 2024

BUY BUY BUY BUY BUY

NOW IS THAT TIME 
Nibinator - October 30, 2023

Real stock price share value

0.05$
Nibinator - October 30, 2023

2023 vs LY

Anyone see value here now at these prices below 10cents? Given how the original investors have taken a beating from launch, must be some...
Vikingstock - January 12, 2023

Small CAP "bio" no coming in vogue

Get ready for a run in "small caps" especially in bio-tech sector.  GTTX could be one of them on their way up! GLTA
CashFlowReality - November 17, 2022
View more Bullboard ››

North Arrow Minerals Inc.

North Arrow Minerals Inc.

North Arrow Minerals Inc. is a Canada-based exploration company. The Company is focused on the identification and evaluation ...
View More »